用于鼻整形术后护理的集成式硅胶夹板与鼻孔保持器：Tezel夹板技术。

文献信息

中文摘要

涉及鼻中隔重建和下鼻部三分之一畸形的鼻整形手术，在术后早期可能需要同时支撑鼻中隔、外鼻瓣和鼻孔轮廓。然而，常规鼻内硅胶夹板和鼻孔保持器的同时使用可能受到可用鼻内空间的限制。本研究描述了Tezel夹板技术，这是一种技术改良，将市售鼻孔保持器与鼻内硅胶夹板整合，以提供同时的术后支撑。回顾性连续分析了2023年至2025年间接受初次、二次、三次、创伤后或唇裂相关鼻整形的127例患者。集成系统在98例患者（77.2%）中维持7天，在29例患者（22.8%）中维持10天。34例患者（26.8%）需要不对称的鼻孔保持器尺寸。该技术在所有患者中成功组装并应用，并在预期的夹板期间保持稳定，无计划外提前移除。12例患者（9.4%）因夹板气道有效内径减小而出现暂时性鼻气道阻塞，在移除集成系统后缓解。未观察到重大器械相关并发症。Tezel夹板技术提供了一种在单一术后结构中结合鼻中隔稳定和下鼻部三分之一支撑的实用方法。本临床系列证明了其在异质性鼻整形人群中的技术可行性和短期临床适用性，但未确立其相对于常规术后夹板方法的比较疗效。

英文摘要

Rhinoplasty procedures involving septal reconstruction and lower nasal third deformities may require simultaneous support of the septum, external nasal valve, and nostril contour during the early postoperative period. However, concurrent use of conventional intranasal silicone splints and nostril retainers may be limited by the available intranasal space. This study describes the Tezel Splinting Technique, a technical modification that integrates a commercially available nostril retainer with an intranasal silicone splint to provide simultaneous postoperative support. A retrospective consecutive series of 127 patients who underwent primary, secondary, tertiary, post-traumatic, or cleft-related rhinoplasty between 2023 and 2025 was reviewed. The integrated system was maintained for 7 days in 98 patients (77.2%) and for 10 days in 29 patients (22.8%). Asymmetric nostril retainer sizing was required in 34 patients (26.8%). The technique was successfully assembled and applied in all patients and remained stable throughout the intended splinting period without unplanned early removal. Transient nasal airway obstruction occurred in 12 patients (9.4%) because of a reduction in the effective internal diameter of the splint airway and resolved after removal of the integrated system. No major device-related complications were observed. The Tezel Splinting Technique provides a practical method for combining septal stabilization and lower nasal third support within a single postoperative construct. This clinical series demonstrates its technical feasibility and short-term clinical applicability across a heterogeneous rhinoplasty population without establishing comparative efficacy over conventional postoperative splinting methods.